jocelynhudson

26 POSTS 0 COMMENTS

Reaction to the Katsanos et al meta-analysis

Internal BIBA MedTech data show that perceptions on paclitaxel devices have shifted considerably in the twelve months that have elapsed since Konstantinos Katsanos (Patras,...

More trained interventionalists needed to treat stroke “on the spot”

Nick Hopkins (Buffalo, USA) talks to BLearning Neuro at VEITH Symposium 2018 (13–17 November 2018, New York, USA) about the DAWN trial, which showed that in carefully selected acute...

Benefit and risk: Meta-analysis draws a heterogeneous picture of drug-coated balloon...

Scientists of Jena University Hospital, Germany, conducted a meta-analysis sought to evaluate benefit and risk of paclitaxel-coated balloon angioplasty compared to plain old balloon...

Philips receives FDA approval for low-dose drug-coated balloons

Philips has received US Food and Drug Administration (FDA) approval for two Stellarex 0.035” low-dose (200mm and 150mm) drug-coated balloons for the treatment of...

No evidence of increased mortality with paclitaxel-based devices in German claim...

A real-world safety analysis of paclitaxel-based devices in peripheral arteries, recently published in the European Heart Journal, showed no evidence for increased mortality over...

Medtronic receives FDA breakthrough device designation for its Valiant Navion LSA...

Medtronic today announced it has received breakthrough device designation from the US Food and Drug Administration (FDA) for its Valiant TAAA stent graft system...

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy

Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing...

BD announces publication of drug-coated balloon safety data for femoropopliteal PAD

BD has announced the publication of a company-initiated, independent analysis of the Lutonix 035 drug-coated balloon (DCB) femoropopliteal clinical programme in the Journal of...

TINTIN trial shows “impressive” results at six months

The six-month results of TINTIN (Treatment with the lumINor DCB and The IVolutioN self-expanding stent) trial have been revealed at the annual meeting of the Cardiovascular and...

LimFlow receives FDA approval for US study of minimally-invasive technology designed...

LimFlow has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) for the PROMISE II pivotal study of...

Orchestra BioMed announce FDA breakthrough device designation for Virtue sirolimus-eluting balloon

Orchestra BioMed, in partnership with Terumo Corporation, today announced that the company has secured breakthrough device designation by the US Food and Drug Administration...

FDA clears Artis icono family of angiography systems from Siemens Healthineers

The US Food and Drug Administration (FDA) has cleared the Artis icono, a family of angiography systems from Siemens Healthineers that permit a range...

Proximo Medical named commercialisation partner for Biotronik’s PVI portfolio in select...

pulsar
According to a press release, Proximo Medical has been announced as the commercial partner for Biotronik's peripheral vascular intervention (PVI) platform in select US markets.  Proximo Medical is...

Novel paclitaxel-nano-coated balloon achieves lower incidence of restenosis than plain balloon...

  Two-year results of EffPac—a randomised controlled trial to assess the safety and efficacy of a novel drug-coated balloon (DCB) with a nanotechnology coating—have been...

First patient enrolled in Cook Regentec’s clinical trial of investigational therapy...

Cook Regentec has announced enrolment of the first patient in an international clinical trial evaluating the HemaTrate Blood Filtration System to treat patients with...

New Cook Medical paclitaxel data confirm safety of Zilver PTX

New data on the use of Zilver PTX, Cook Medical’s paclitaxel-coated stent for peripheral arterial disease (PAD), confirms the safety of the device. These...

Beacon Tip catheters available in Europe again

Beacon Tip catheters (Cook Medical) are once again available to physicians in Europe. As of September 2019, the catheters are available in the UK,...

MagicTouch AVF sirolimus-coated balloon granted FDA breakthrough device designation

breakthrough
Concept Medical has been granted breakthrough device designation from the US Food and Drug Administration (FDA) for MagicTouch AVF, its sirolimus drug-coated balloon (DCB)...

Surmodics completes enrolment in pivotal TRANSCEND clinical trial

According to a press release, Surmodics has completed enrolment in TRANSCEND, its pivotal clinical trial for the SurVeil drug-coated balloon (DCB). “TRANSCEND is a rigorous...

Cardiovascular Systems announces first patient enrolled in REACH PVI clinical study

Cardiovascular Systems recently announced that the first patient has been enrolled in the REACH PVI study. The purpose of this study is to prospectively...

Endologix announces reinstatement of CE mark for its Nellix endovascular aneurysm...

nellix
Endologix recently announced that the EC Certificate of Conformity (CE mark) for the Nellix endovascular aneurysm sealing system (Nellix system) has been reinstated by...

Eluvia drug-eluting stent continues to demonstrate positive outcomes in IMPERIAL trial...

Boston Scientific has announced results from sub-analyses of the IMPERIAL clinical trial for the Eluvia Drug-Eluting Vascular Stent System. Data demonstrated that the efficacy...

Canon Medical Systems launches Alphenix interventional imaging line

Canon Medical Systems USA recently introduced its next generation of interventional systems—the Alphenix platform. The new platform of systems incorporates all-new features that enable clinicians...

Gore Tigris vascular stent demonstrates high patency rates at 12 months

New results suggest that the Tigris vascular stent (Gore) is a safe and effective device that can be incorporated into a modern “leave-nothing-behind” treatment...

Vascular Dynamics names Martin Rothman chief medical officer

Martin T Rothman has been appointed as chief medical officer of Vascular Dynamics, effective 1 January 2019. Rothman is a pioneer in interventional cardiology, as...

BELONG study enrols first patients

Enrolment of the first patients in the BELONG study—benefit of arterial vessel preparation by arterial by longitudinal micro-incisions before drug-eluting balloon angioplasty of the...